Have a personal or library account? Click to login
Simultaneous determination of pyrrolizidine and tropane alkaloids in honey by liquid chromatography–mass spectrometry Cover

Simultaneous determination of pyrrolizidine and tropane alkaloids in honey by liquid chromatography–mass spectrometry

Open Access
|Jul 2022

Figures & Tables

Fig. 1

Results of honey sample alkaloid investigation expressed as percentage of samples contaminated and not contaminated and percentage distribution of determined alkaloids in the contaminated samples
Results of honey sample alkaloid investigation expressed as percentage of samples contaminated and not contaminated and percentage distribution of determined alkaloids in the contaminated samples

Fig. 2

Boxplots of the concentration of determined alkaloids
Boxplots of the concentration of determined alkaloids

Fig. 3

a) SIM chromatogram obtained for honey matrix spiked at a concentration of 5 μg kg−1. 1 – monocrotaline, 2 – erucifoline, 3 – intermedine, 4 – europine, 5 – lycopsamine, 6 – jacobine, 7 – scopolamine, 8 – retrorsine, 9 – trichodesmine, 10 – heliotrine, 11 – seneciphylline, 12 – atropine, 13 – senecivernine, 14 – senecionine, 15 – echimidine, 16 – senkirkine, 17 – lasiocarpine; b) chromatogram of a blank honey sample
a) SIM chromatogram obtained for honey matrix spiked at a concentration of 5 μg kg−1. 1 – monocrotaline, 2 – erucifoline, 3 – intermedine, 4 – europine, 5 – lycopsamine, 6 – jacobine, 7 – scopolamine, 8 – retrorsine, 9 – trichodesmine, 10 – heliotrine, 11 – seneciphylline, 12 – atropine, 13 – senecivernine, 14 – senecionine, 15 – echimidine, 16 – senkirkine, 17 – lasiocarpine; b) chromatogram of a blank honey sample

Alkaloid contamination results for the honey samples tested

IntermedineLycopsamineSenecionineSenecivernineEchimidineRetrorsineSeneciphyllineErucifolineTotal
02/p 3.01.9 6.9 11.8
03/p2.22.82.2 7.3 14.5
06/f23.322.5 101.2 147.0
07/p2.23.21.9 7.3
09/f2.9 10.2 13.1
10/p 3.02.1 4.1 9.2
11/f 1.8 4.0 5.8
14/f 120.0 120.0
15/p 5.9 5.9
16/p9.214.12.0 6.3 31.6
19/f 2.73.0 4.3 4.514.5
22/p7.15.3 4.3 16.7
25/p8.7 8.7
27/p 2.2 2.2
28/p 2.5 2.5

Monitored ions (m/z), retention time, matrix effect, determination coefficient (R2), limit of detection (LOD) and limit of quantification (LOQ) of analysed pyrrolizidine and tropane alkaloids

Monitored ion (m/z)Retention time (min)Matrix effect (%)Linearity R2LOD μg kg−1LOQ μg kg−1Uncertainty (%)
Monocrotaline326.15.261010.99240.160.529.8
Erucifoline350.17.60950.99330.100.3512.9
Intermedine300.18.141150.99000.090.3119.0
Europine330.18.371150.99290.170.5824.3
Lycopsamine300.18.541160.98770.090.2822.1
Jacobine352.19.07940.99220.130.4417.6
Retrorsine352.111.49970.99040.090.2921.4
Trichodesmine354.111.651010.99450.130.4413.7
Heliotrine314.112.191190.99520.110.3717.7
Seneciphylline334.112.79960.99440.100.3413.7
Senecivernine336.115.47980.99400.130.4314.2
Senecionine336.115.73910.99010.090.2917.1
Echimidine398.117.251030.99410.160.5325.5
Senkirkine366.117.441130.99390.050.175.6
Lasiocarpine412.118.891150.99350.060.2113.4
Scopolamine304.110.281050.99220.150.4915.5
Atropine290.114.361270.99420.110.3614.7

Validation results for recovery, repeatability and within-laboratory reproducibility

Recovery (%)Repeatability CV (%)Reproducibility CV (%)
Concentration550200550200550200
Monocrotaline92.696.591.25.73.84.67.98.67.6
Erucifoline90.696.994.95.44.18.08.66.27.9
Intermedine100.298.288.65.29.613.37.89.812.6
Europine98.695.981.23.911.412.98.511.117.4
Lycopsamine97.195.684.54.711.612.49.511.815.4
Jacobine94.0100.692.13.34.510.08.06.79.6
Retrorsine83.997.792.17.212.711.017.813.912.8
Trichodesmine94.797.289.49.05.07.311.97.58.8
Heliotrine99.9100.392.87.45.79.76.77.59.8
Seneciphylline90.399.495.57.73.58.29.98.08.1
Senecivernine100.0104.096.13.52.78.35.76.58.8
Senecionine96.2100.190.91.77.08.97.88.211.1
Echimidine98.999.689.06.59.113.38.39.816.4
Senkirkine99.4104.292.93.81.57.66.53.47.6
Lasiocarpine106.3103.193.04.44.36.85.04.610.6
Scopolamine83.9102.590.78.93.57.89.48.17.8
Atropine88.6102.289.06.43.610.47.35.110.3
Language: English
Page range: 235 - 243
Submitted on: Jan 13, 2022
|
Accepted on: Jun 20, 2022
|
Published on: Jul 5, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Ewelina Kowalczyk, Krzysztof Kwiatek, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.